Coca-Cola Europacific Partners has had a rough week — down 7.7% to €90.50 — and the scale of that move stands out against a peer group that barely flinched.
The divergence from peers is the most striking feature of this week's tape. Coca-Cola HBC fell 5.1% and Britvic dropped 7.2%, so some sector softness was clearly in play. But the two most liquid beverage bellwethers — KO and PEP — gave back only 1.9% and 2.6% respectively. Heineken lost 2.5%. CCEP's move was roughly three times the average of its closest correlated peers, suggesting something specific to the stock drove the bulk of the sell-off. The earnings history offers context: CCEP reported on August 4 — the same day the stock fell 3.8% on the day — though no price-reaction data for that print has yet been filed.
The lending market offers no signs of active short pressure behind the move. Availability has actually expanded sharply this week — jumping 68% to 2,743%, meaning there are nearly 28 shares available to borrow for every one already lent out. That is comfortably above even the 52-week floor of 428%. Borrowing costs remain negligible at 0.51%, roughly where they have been for months. Short interest accounts for a small fraction of the float, and the ORTEX short score of 30 has drifted only marginally higher over the past ten days. None of this points to a short-driven dislocation — the bear case here is not being pressed through the borrow market.
The ownership picture helps explain why the stock can move sharply on news without a large speculative hand involved. Strategic holders dominate the register. COBEGA holds 37.6% and The Coca-Cola Company a further 17.9% — between them they own well over half the company, and neither has moved a single share in recent reporting periods. BlackRock added modestly at the margin through June, as did MFS and Invesco. With so much of the float held passively or strategically, the tradeable float is relatively thin, which amplifies price moves when sentiment shifts. Insider activity over the past 90 days has been largely nominal — a handful of routine awards and two small C-suite sales in June totalling under €600,000 combined.
Valuation multiples are moving slowly but directionally. The PE ratio has drifted up about 0.3 points over 30 days to 20.4x, while EV/EBITDA has nudged down 0.1x to 13.1x — neither dramatic nor rerated. Factor scores reflect a stock the market respects more for income than growth: the dividend score ranks in the 84th percentile, while forward EPS growth ranks in the bottom quarter of the universe at 24. Analyst data is too stale (last recorded January 2021) to draw anything useful from price targets. The most recent ORTEX note from early August flagged only 1.4% return potential from consensus, implying the Street had already been running a fairly tight leash on the stock before this week's drop.
The next scheduled catalyst is the Q4 earnings announcement on October 30. Between now and then, the key question is whether the August 4 report contained anything that changes the medium-term volume or margin outlook — the speed of this week's re-rating relative to sector peers suggests the market thinks it might.
See the live data behind this article on ORTEX.
Open CCEP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
